The closing price of Adverum Biotechnologies Inc (NASDAQ: ADVM) was $1.70 for the day, down -1.73% from the previous closing price of $1.73. In other words, the price has decreased by -$0.0300 from its previous closing price. On the day, 8301076 shares were traded.
Ratios:
Our analysis of ADVM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.32 and its Current Ratio is at 4.32. In the meantime, Its Debt-to-Equity ratio is 0.74 whereas as Long-Term Debt/Eq ratio is at 0.63.
SVB Leerink Downgraded its Outperform to Mkt Perform on May 03, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 07 ’24 when Lupher, Jr. Mark L. bought 130,000 shares for $1.35 per share. The transaction valued at 175,500 led to the insider holds 130,000 shares of the business.
Scopa James Paul bought 100,000 shares of ADVM for $135,000 on Feb 07 ’24. The Director now owns 100,000 shares after completing the transaction at $1.35 per share. On Sep 15 ’23, another insider, Seyedkazemi Setareh, who serves as the Chief Development Officer of the company, sold 6,201 shares for $1.52 each. As a result, the insider received 9,429 and left with 47,674 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADVM now has a Market Capitalization of 356.32M and an Enterprise Value of 314.76M. For the stock, the TTM Price-to-Sale (P/S) ratio is 97.83 while its Price-to-Book (P/B) ratio in mrq is 1.67. Its current Enterprise Value per Revenue stands at 87.43 whereas that against EBITDA is -2.51.
Stock Price History:
Over the past 52 weeks, ADVM has reached a high of $2.97, while it has fallen to a 52-week low of $0.68. The 50-Day Moving Average of the stock is 1.5458, while the 200-Day Moving Average is calculated to be 1.4074.
Shares Statistics:
ADVM traded an average of 1.95M shares per day over the past three months and 2.11M shares per day over the past ten days. A total of 207.16M shares are outstanding, with a floating share count of 149.37M. Insiders hold about 27.90% of the company’s shares, while institutions hold 33.33% stake in the company. Shares short for ADVM as of Feb 29, 2024 were 5.43M with a Short Ratio of 2.78, compared to 1.22M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.62% and a Short% of Float of 2.64%.
Earnings Estimates
The firm’s stock currently is rated by 6 analysts. On average, analysts expect EPS of -$0.34 for the current quarter, with a high estimate of -$0.28 and a low estimate of -$0.4, while EPS last year was -$0.33. The consensus estimate for the next quarter is -$0.25, with high estimates of -$0.16 and low estimates of -$0.33.
Analysts are recommending an EPS of between -$1.2 and -$1.33 for the fiscal current year, implying an average EPS of -$1.26. EPS for the following year is -$0.86, with 6 analysts recommending between -$0.6 and -$1.2.
